Stockscreener 앱 받기
0.99
7.48%
-0.08
Coherus Oncology Inc (CHRS) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
| Revenues |
16.22%
14.31
|
12.31 | 12.75 | 11.57 | 10.25 |
| Cost Of Revenue |
11.22%
4.242
|
3.814 | 4.045 | 3.721 | 3.395 |
Selling, General, and Administrative
|
9.31%
20.95
|
23.10 | - | - | - |
| Interest Income/Expense |
6.27%
2.323
|
2.186 | 2.249 | 2.325 | 2.277 |
| Costs And Expenses |
3.76%
46.64
|
48.46 | 58.63 | 55.90 | 55.74 |
| Depreciation and Amortization |
2.16%
0.862
|
0.881 | 0.896 | 0.966 | 1.016 |
| Operating Income/Loss |
10.57%
-32.33
|
-36.15 | -45.88 | -44.33 | -45.49 |
| Income/Loss From Continuing Operations Before Tax |
9.71%
-33.35
|
-36.94 | -46.35 | -44.52 | -44.86 |
| Income/Loss From Continuing Operations After Tax |
9.71%
-33.35
|
-36.94 | -46.35 | -44.52 | -44.86 |
| Income/Loss From Discontinued Operations, Net Of Tax |
1,014%
12.72
|
-1.392 | 8.704 | 8.986 | 342.63 |
| Net Income/Loss |
46.17%
-20.63
|
-38.33 | -37.64 | -35.53 | 297.77 |
| Basic Average Shares |
13.50%
154.82
|
136.40 | 1.0872 | 116.23 | 116.08 |
| Diluted Average Shares |
13.50%
154.82
|
136.40 | 1.0872 | 116.23 | 116.08 |
| Basic Earnings Per Share |
53.57%
-0.13
|
-0.28 | -0.34 | -0.31 | 2.57 |
| Diluted Earnings Per Share |
53.57%
-0.13
|
-0.28 | -0.34 | -0.31 | 2.57 |
4.22%
자본화:
|
볼륨(24시간):